Observers were presented with a flickering red (650 nm) target superimposed in the centre of a moderate-intensity blue (481 nm) background field. They were asked to set the highest temporal frequency at which the flicker appeared to be just visible -also 
As an undesirable side effect, sildenafil citrate (Viagra) partially inhibits the phosphodiesterase PDE6 [1] , which plays an essential role in phototransduction (reviewed in [2, 3] ). PDE6 not only activates the visual transduction cascade, but also controls the time over which the visual response is integrated, thereby helping to maintain the size of the visual response within an optimal range as the light level is increased [4] . Consistent with an increase in temporal integration following Viagra ingestion, performance improvements have been reported for an identification task that relies on the integration of two temporally separated stimuli [5] . Using more conventional psychophysical measures of temporal sensitivity and resolution [6, 7] , we find that therapeutic 100 mg doses of Viagra can cause mild to moderate transient losses in human temporal visual sensitivity. These losses imply that in the more affected observers, Viagra may provide a unique tool for pharmacologically manipulating the activity of PDE6 in humans in vivo, and thus for investigating the role of PDE6 in light adaptation. At the light levels tested, the frequency-dependent sensitivity losses caused by the inhibition of PDE6 by Viagra are consistent with an almost doubling of the time over which visual events are normally integrated (from ~6.9 to 12.6 ms, assuming a single integration stage).
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